|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-9-25
|
|
pubmed:abstractText |
We conducted a phase 1 trial to determine the maximum tolerated dose (MTD) of weekly docetaxel delivered concurrently with radiation therapy for the treatment of locally advanced adenocarcinoma of the pancreas.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1536-4828
|
|
pubmed:author |
pubmed-author:BoriesEE,
pubmed-author:BraunA MAM,
pubmed-author:CamerloJJ,
pubmed-author:DuboisJ BJB,
pubmed-author:GenreDD,
pubmed-author:GiovanniniMM,
pubmed-author:GonçalvesAA,
pubmed-author:GravisGG,
pubmed-author:MagninVV,
pubmed-author:MaraninchiDD,
pubmed-author:MoutardierVV,
pubmed-author:ViensPP,
pubmed-author:ViretFF,
pubmed-author:YchouMM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
214-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14508124-Adenocarcinoma,
pubmed-meshheading:14508124-Aged,
pubmed-meshheading:14508124-Disease Progression,
pubmed-meshheading:14508124-Female,
pubmed-meshheading:14508124-Humans,
pubmed-meshheading:14508124-Infusions, Intravenous,
pubmed-meshheading:14508124-Male,
pubmed-meshheading:14508124-Middle Aged,
pubmed-meshheading:14508124-Pancreatic Neoplasms,
pubmed-meshheading:14508124-Taxoids,
pubmed-meshheading:14508124-Time Factors
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Docetaxel and radiotherapy and pancreatic cancer.
|
|
pubmed:affiliation |
Department of Medicine, Institut Paoli-Calmettes, Marseille, France. viretf@marseille.fnclcc.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase I
|
